NCT04652115View on ClinicalTrials.gov

Defibrotide for the Treatment of Severe COVID-19

PHASE2RecruitingINTERVENTIONAL

Enrollment

42

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

September 1, 2024

Study Completion Date

March 1, 2025

Conditions

Covid19

Interventions

DRUG

Defibrotide

Deibrotide via IV

Trial Locations (1)

02214

RECRUITING

Brigham and Women's Hospital, Boston

Sponsors

Collaborators (1)

Jazz Pharmaceuticals

All Listed Sponsors

collaborator

Jazz Pharmaceuticals

INDUSTRY

lead

Brigham and Women's Hospital

OTHER